natgillin/translations-raw huggingface dataset:
The absolute bioavailability of the vemurafenib 240 mg tablet is unknown.
Absolutna biološka uporabnost 240-mg tablet vemurafeniba ni znana.
The absolute bioavailability of tolvaptan is about 56%.
Absolutna biološka uporabnost tolvaptana je približno 56 %.
The absolute bioavailability of ustekinumab following a single subcutaneous administration was estimated to be 57.2% in patients with psoriasis.
O sekundarnem prenosu okužb z živimi cepivi pri bolnikih, ki prejemajo zdravilo STELARA ni podatkov.
The absolute change in HbA1c at one year was -0.6 for rimonabant 20 mg (baseline 7.3%) and +0.1 on placebo (baseline 7.2%).
Po enem letu je bila absolutna sprememba HbA1c z 20 mg rimonabanta –0,6 (izhodiščno 7,3 %) in s placebom +0,1 (izhodiščno
The absolute difference in objective soft tissue response between enzalutamide and placebo arms was 53.9% (95% CI: 48.5%, 59.1%, p < 0.0001).
Absolutna razlika v objektivnem odzivu mehkega tkiva med krakoma z enzalutamidom in placebom je bila 53,9 % (95-odstotni IZ: 48,5 %; 59,1 %, p < 0,0001).
The absolute oral bioavailability has not been determined.
Absolutne peroralne biološke uporabnosti niso določili.
The absolute oral bioavailability of duloxetine ranged from 32% to 80% (mean of 50%).
Absolutna peroralna biološka uporabnost duloksetina zavzema vrednosti od 32 do 80 % (povprečje 50 %; N=8 oseb).
The absolute oral bioavailability of lomitapide is 7%.
Absolutna peroralna biološka uporabnost lomitapida je 7 %.
The absorbed dose to the uterus following administration of Yttrium (90Y)-labelled medicinal products is dependent on the specific medicinal product being radiolabelled and is to be specified in the Summary of Product Characteristics/ package leaflet of the medicinal product to be radiolabelled.
Absorbirana doza sevanja za maternico po aplikaciji z itrijem (90Y) označenega zdravila je odvisna od posameznega zdravila, ki se označuje, in mora biti navedena v Povzetku glavnih značilnosti zdravila/navodilu za uporabo zdravila, ki naj bi ga označili z radioaktivnim izotopom.
The absorption and bioavailability of Tasigna are increased if it is taken with food, resulting in a higher serum concentration (see sections 4.2, 4.4 and 5.2).
Pri zaužitju zdravila Tasigna skupaj s hrano se njegovi absorpcija in biološka uporabnost povečata, kar povzroči višjo koncentracijo v serumu (glejte poglavja 4.2, 4.4 in 5.2).
The absorption of atazanavir is pH-dependent.
Absorpcija atazanavirja je odvisna od pH.
The absorption of dolutegravir is reduced by certain anti-acid agents (see Table 1).
Določena antacidna zdravila zmanjšujejo absorpcijo dolutegravirja (glejte Preglednico 1).
The absorption of dolutegravir is reduced by certain anti-acid agents (see Table 1).
Določeni antacidi zmanjšujejo absorpcijo dolutegravirja (glejte Preglednico 1).
The absorption of eluxadoline was rapid under fasting conditions, with a median Tmax value of 2 hours.
Absorpcija eluksadolina na tešče je bila hitra, s srednjo vrednostjo Tmax 2 uri.
The absorption of ibandronic acid in the upper gastrointestinal tract is rapid after oral administration.
Po peroralnem jemanju je absorpcija ibandronske kisline v zgornjem delu prebavil hitra.
The absorption of lipid soluble drugs used concomitantly with mitratapide has not been investigated.
Absorpcije zdravil, topnih v lipidih, ki so se uporabila sočasno z mitratapidom niso raziskali.
The absorption of liraglutide following subcutaneous administration is slow, reaching maximum concentration 8­12 hours post dosing.
Absorpcija liraglutida po subkutanem odmerku je počasna; največjo koncentracijo doseže v 8-12 urah po odmerku.
The absorption of posaconazole is significantly increased by food (see sections 4.2 and 5.2).
Absorpcija posakonazola se bistveno poveča s hrano (glejte poglavji 4.2 in 5.2).
The absorption of rosiglitazone is not affected by increases in gastric pH.
Zvišanje pH v želodcu ne vpliva na absorpcijo rosiglitazona.
The absorption rate was somewhat slower in type 2 diabetic patients, resulting in a lower Cmax (352240 pmol/l) and later tmax (60 (interquartile range: 50–90) minutes).
Pri bolnikih s sladkorno boleznijo tipa 2 je bila hitrost absorpcije nekoliko počasnejša, zato je bila Cmax manjša (352  240 pmol/l), tmax pa poznejši (60 (interkvartilni razpon: 50–90) minut).
The accompanying solvent of Valtropin contains metacresol.
Priloženi vehikel zdravila Valtropin vsebuje metakrezol.
The accumulation ratio after once daily dosing ranged from 1.9 to
Kopičenje po enkratnem dnevnem odmerku je segalo od 1,9 do 2,3.
The accuracy and precision of the test depends heavily on the quality of the analysis and therefore only laboratories having appropriate certification are considered qualified to analyse the breath samples.
Zato so le laboratoriji z ustreznim certifikatom primerni za analizo vzorcev izdihanega zraka.
The accuracy and precision of the test depends heavily on the quality of the analysis and therefore only laboratories having appropriate certification are considered qualified to analyse the breath samples.
Zato so za analizo vzorcev izdihanega zraka primerni le laboratoriji z ustreznim certifikatom.
The accuracy of the test strongly depends on the quality of the breath analysis.
Natančnost testa je močno odvisna od kakovosti analize izdihanega zraka.
The accuracy of the test strongly depends on the quality of the breath analysis.
Natančnost testa je močno odvisna od kvalitetne analize izdihanega zraka.
the acid pump and inhibits both basal and stimulated acid secretion.
Zavre bazalno in stimulirano izločanje želodčne kisline.
The ACR response rates were numerically lower for patients with prior biologic treatment as shown in Table 9 below.
Odzivi ACR so bili številčno nižji pri bolnikih, ki so se predhodno že zdravili z biološkimi zdravili, kar je prikazano v preglednici 9 spodaj.
The ACR responses in Study V were consistent with the DAS28 score.
V študiji V so bili odzivi ACR konsistentni z rezultatom DAS28.
The ACT increased in all patients – from neonates to older children as well as adults- with increasing bivalirudin concentrations.
ACT se je pri vseh bolnikih povečal, od novorojenčkov do starejših otrok ter odraslih, z večanjem koncentracij bivalirudina.
The activated partial thomboplastin time (aPTT) and HepTest are also prolonged dose-dependently; however, they are not recommended to assess the pharmacodynamic effect of rivaroxaban.
Podaljšanje aktiviranega parcialnega tromboplastinskega časa (aPTČ) in HepTest sta prav tako odvisna od odmerka; preiskavi nista priporočljivi za ocenjevanje farmakodinamičnega učinka rivaroksabana.
The active components in vivo are clomipramine and its major metabolite, desmethylclomipramine.
Glavni učinkovini zdravila Clomicalm sta klomipramin in njegov glavni metabolit desmetilklomipramin.
The active ingredient (orlistat) in alli is designed to target fat in your digestive system.
Zdravilna učinkovina v zdravilu alli (orlistat) je oblikovana tako, da deluje na maščobe v vašem prebavnem sistemu.
The active ingredient hydrochlorothiazide can cause an unusual reaction, resulting in a decrease in vision and eye pain.
Učinkovina hidroklorotiazid lahko povzroči neobičajno reakcijo, katere posledica sta poslabšan vid in očesna bolečina.
The active ingredient in Avonex is a protein called interferon beta-1a.
Zdravilna učinkovina v zdravilu Avonex je protein, ki se imenuje interferon beta-1a.
The active ingredient in BeneFIX is nonacog alfa.
Zdravilna učinkovina v zdravilu BeneFIX je nonakog alfa.
The active ingredient in BLINCYTO is blinatumomab.
Zdravilna učinkovina v zdravilu BLINCYTO je blinatumomab.
The active ingredient in CELSENTRI is maraviroc.
Zdravilna učinkovina v zdravilu CELSENTRI je maravirok.
The active ingredient in Enbrel is etanercept.
Zdravilna učinkovina zdravila Enbrel je etanercept.
The active ingredient in Epivir is lamivudine.
Zdravilna učinkovina v zdravilu Epivir je lamivudin.
The active ingredient in Lamivudine Teva is lamivudine.
Zdravilna učinkovina v zdravilu Lamivudin Teva je lamivudin.
The active ingredient in Lamivudine Teva Pharma B.V. is lamivudine.
Účinná látka v Lamivudine Teva Pharma B.V. je lamivudín.
The active ingredient in MabThera is called rituximab.
Zdravilna učinkovina zdravila MabThera je rituksimab.
The active ingredient in Spedra, avanafil, belongs to a group of medicines called phosphodiesterase- type-5 (PDE5) inhibitors.
Zdravilna učinkovina v zdravilu Spedra, avanafil, spada v skupino zdravil, imenovanih zaviralci fosfodiesteraze tipa 5 (PDE5).
The active ingredient in the product is highly lipophilic and binds to skin and may also bind to surfaces after spillage of the product.
Aktivna sestavina v tem zdravilu je zelo lipofilna in se veže na kožo, lahjko pa se veže tudi na površine, če se zdravilo polije.
The active ingredient in the product is highly lipophilic and binds to skin and may also bind to surfaces after spillage of the product.
Aktivna sestavina v tem zdravilu je zelo lipofilna in se veže na kožo, lahko pa se veže tudi na površine, če se zdravilo polije.
The active ingredient in Zeffix is lamivudine.
Zdravilna učinkovina v zdravilu Zeffix je lamivudin.
The active ingredient is belimumab.
Zdravilna učinkovina je belimumab.
The active ingredient is cangrelor.
Zdravilna učinkovina je kangrelor.
The active ingredient is propranolol.
Zdravilna učinkovina je propranolol.
The active ingredient is rituximab.
Zdravilna učinkovina je rituksimab.
The active ingredient is: Interferon beta-1a 30 micrograms
Zdravilna učinkovina je: 30 mikrogramov interferona beta-1a.
The active ingredient is: Interferon beta-1a 30 micrograms/0.5 ml
Zdravilna učinkovina je: 30 mikrogramov interferona beta-1a/0,5 ml.
The active ingredient is: peginterferon beta-1a.
Zdravilna učinkovina je: peginterferon beta-1a.
The active ingredient of Bretaris Genuair is aclidinium bromide, which belongs to a group of medicines called bronchodilators.
Zdravilna učinkovina zdravila Bretaris Genuair je aklidinijev bromid, ki spada v skupino zdravil, imenovanih bronhodilatatorji.
The active ingredient of Eklira Genuair is aclidinium bromide, which belongs to a group of medicines called bronchodilators.
Zdravilna učinkovina zdravila Eklira Genuair je aklidinijev bromid, ki spada v skupino zdravil, imenovanih bronhodilatatorji.
The active ingredient of Imlygic is talimogene laherparepvec.
Zdravilna učinkovina v zdravilu Imlygic je talimogen laherparepvek.
The active ingredient of INVANZ is ertapenem 1 g.
Zdravilna učinkovina je ertapenem 1 g.
The active ingredient sucroferric oxyhydroxide contains 750 mg sucrose and 700 mg starches.
Zdravilna učinkovina saharoznega železovega oksihidroksida vsebuje 750 mg saharoze in 700 mg škroba.
The active ingredient vortioxetine (D,L)-lactate is classified as a PBT-substance (persistent, bioaccumulative and toxic; risk to fish).
Zdravilna učinkovina vortioksetinijev (D,L)-laktat je klasificirana kot PBT snov (obstojna, bioakumulativna in strupena, tveganje za ribe).
The active ingredient vortioxetine hydrobromide is classified as a PBT-substance (persistent, bioaccumulative and toxic; risk to fish).
Zdravilna učinkovina vortioksetinijev bromid je klasificirana kot PBT snov (obstojna, bioakumulativna in strupena, tveganje za ribe).
The active ingredient, cytarabine, was mutagenic in in vitro tests and was clastogenic in vitro (chromosome aberrations and sister chromatid exchange in human leukocytes) and in vivo (chromosome aberrations and sister chromatid exchange assay in rodent bone marrow, mouse micronucleus assay).
Zdravilna učinkovina citarabin je bila mutagena v raziskavah in vitro ter klastogena v raziskavah in vitro (kromosomske aberacije in izmenjava med sestrskimi kromatidami v človeških levkocitih) in in vivo (test kromosomskih aberacij in izmenjave med sestrskimi kromatidami v kostnem mozgu glodalcev, test mikronukleusov pri miših).
The active ingredients are as follows:
Zdravilne učinkovine so naslednje:
The active ingredients of CE are primarily the sulphate esters of estrone, equilin sulphates and 17α/β- estradiol.
Zdravilne učinkovine CE so predvsem sulfatni estri estrona, ekvilinski sulfati in 17α/β-estradiol.
The active ingredients of the vaccine are purified viral proteins (called haemagglutinin and neuraminidase).
Zdravilni učinkovini cepiva sta prečiščeni virusni beljakovini (imenovani hemaglutinin in nevraminidaza).
The active metabolite has a half-life of 6.2–13.5 h.
Aktivni presnovek ima razpolovni čas 6,2–13,5 h.
The active metabolite is formed mostly by CYP2C19 with contributions from several other CYP enzymes, including CYP1A2, CYP2B6 and CYP3A4.
Aktivni presnovek nastane predvsem z delovanjem CYP2C19, k nastanku pa pripomorejo tudi drugi encimi CYP, vključno s CYP1A2, CYP2B6 in CYP3A4..
The active metabolite is further metabolised in the liver to its carboxy, carboxy-N-desisopropyl, and N-desisopropyl metabolite with involvement of CYP2D6 and CYP3A4.
Aktivni presnovek se potem z encimi CYP2D6 in CYP3A4 presnavlja v jetrih v karboksilni, karboksi-N-desizopropilni in N-desizopropilni presnovek.
The active metabolite, N-desethyloxybutynin, has pharmacological activity on the human detrusor muscle that is similar to that of oxybutynin in vitro studies, but has a greater binding affinity for parotid tissue than oxybutynin.
Aktiven metabolit, N-dezetiloksibutinin, farmakološko vpliva na mišico detruzorja pri človeku, kar je podobno kot učinek oksibutinina pri študijah in vitro, vendar pa je njegova afiniteta za obušesno tkivo večja kot pri oksibutininu.
The active metabolite’s exposure (AUC) has moderate to low between-subject (27%) and within-subject (19%) variability.
Izpostavljenost (AUC) aktivnemu presnovku je zmerno do nizko variabilna med-osebami (27 %) in pri-osebah (19 %).
The active metabolite’s exposure (AUC) increases proportionally over the therapeutic dose range.
Izpostavljenost (AUC) aktivnemu presnovku se povečuje sorazmerno z razponom terapevtskega odmerka.
The active substance (pegaspargase) contains the enzyme asparaginase which works by breaking up and reducing the blood levels of the amino acid asparagine.
Zdravilna učinkovina (pegaspargaza) vsebuje encim asparaginazo, ki razgrajuje aminokislino asparagin in zmanjšuje njeno koncentracijo v krvi.
The active substance accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 μg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 µg/ml.
Zdravilna učinkovina je pospešila reepitelizacijo pri preizkusu in vitro s praskanjem rane z uporabo humanih primarnih keratinocitov z odmerkom 1 μg/ml in pri modelu celjenja rane ex vivo pri prašičih z odmerkom 10 µg/ml.
The active substance and its metabolite are excreted in urine; 55-75 % of the administered dose is excreted unchanged.
Zdravilna učinkovina in njen presnovek se izločata z urinom, pri čemer se od 55 do 75 % danega odmerka izloči v nespremenjeni obliki.
The active substance being a principle of biological origin intended to produce active immunity is not in the scope of Regulation (EC) 470/2009.
Učinkovina biološkega izvora namenjena vzbujanju aktivne imunosti, ni vključena v Uredbo (ES) 470/2009.
The active substance being a principle of biological origin intended to produce active immunity is not in the scope of Regulation (EC) 470/2009.
Učinkovina biološkega izvora namenjena vzbujanju aktivne imunosti, ni vključena v Uredbo (ES) št.
The active substance being a principle of biological origin intended to produce active immunity is not in the scope of Regulation (EC) 470/2009.
Učinkovina biološkega izvora, namenjena vzbujanju aktivne imunosti, ni vključena v Uredbo(ES) št.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Učinkovina biološkega izvora, namenjena vzbujanju aktivne imunosti, ni vključena v Uredbo(ES) št.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No 470/2009.
Zdravilna učinkovina biološkega izvora namenjena za vzpodbudo aktivne imunosti ni vključena v Uredbo(ES) št.
The active substance being a principle of biological origin intended to produce active immunity is not within the scope of Regulation (EC) No.
Učinkovina biološkega izvora, namenjena vzbujanju aktivne imunosti, ni vključena v Uredbo (ES) št.
The active substance being a principle of biological origin intended to produce passive immunity is not within the scope of Regulation (EC) No 470/2009.
Učinkovina biološkega izvora namenjena vzbujanju pasivne imunosti, ni vključena v Uredbo(ES) št.
The active substance cobicistat is persistent in the environment.
Zdravilna učinkovina kobicistat je v okolju obstojna.
The active substance consists of 300,000 - 1,200,000 of your living eye cells, on average 3.5% of which are stem cells.
Zdravilna učinkovina je sestavljena iz 300.000 – 1.200.000 vaših živih očesnih celic, od katerih je povprečno 3,5 % matičnih celic.
The active substance follitropin beta.
Zdravilna učinkovina je folitropin beta.
The active substance ganirelix (INN) is a synthetic decapeptide with high antagonistic activity to the naturally occurring gonadotrophin releasing hormone (GnRH).
Zdravilna učinkovina ganireliks (INN) je sintetični dekapeptid z močnim antagonističnim delovanjem za naravni gonadotropin sproščujoči hormon (GnRH).
The active substance in Ablavar, gadofosveset trisodium, contains gadolinium, a ‘rare-earth’ metal element.
Zdravilna učinkovina zdravila Ablavar, trinatrijev gadofosveset, vsebuje redko zemeljsko kovino gadolinij.
The active substance in Abraxane, paclitaxel, belongs to the group of cancer medicines known as the ‘taxanes’.
Zdravilna učinkovina zdravila Abraxane, paklitaksel, spada v skupino zdravil proti raku, imenovanih taksani.
The active substance in Abseamed, epoetin alfa, is a copy of a hormone called erythropoietin, and works in exactly the same way as the natural hormone to stimulate the production of red blood cells from the bone marrow.
Zdravilna učinkovina v zdravilu Abseamed, epoetin alfa, je kopija hormona eritropoetina in deluje popolnoma enako kot naravni hormon pri spodbujanju nastajanja rdečih krvnih celic v kostnem mozgu.
The active substance in Accofil, filgrastim, is very similar to a human protein called granulocyte colony stimulating factor (G-CSF).
Zdravilna učinkovina v zdravilu Accofil, filgrastim, je zelo podobna človeški beljakovini, ki jo imenujemo granulocitne kolonije stimulirajoči faktor (granulocyte colony stimulating factor – G-CSF).
The active substance in Actos is pioglitazone.
Zdravilna učinkovina zdravila Actos je pioglitazon.
The active substance in Actrapid, human insulin, is produced by a method known as ‘recombinant technology’: the insulin is made by a yeast that has received a gene (DNA), which makes it able to produce insulin.
Zdravilna učinkovina v zdravilu Actrapid, humani insulin, se proizvaja z metodo, znano kot „tehnologija rekombinantne DNK“, pri kateri insulin izdelajo kvasovke, ki prejmejo ustrezni gen (DNK), s pomočjo katerega postanejo sposobne tvoriti insulin.
The active substance in Adcetris, brentuximab vedotin, is made up of a CD30 monoclonal antibody (a type of protein that attaches to CD30).
Zdravilo Adcetris vsebuje zdravilno učinkovino brentuksimab vedotin, narejeno iz monoklonskega protitelesa CD30 (vrste beljakovine, ki se veže na CD30).
The active substance in Adcirca, tadalafil, belongs to a group of medicines called ‘phosphodiesterase type 5 (PDE5) inhibitors’, which means that it blocks the PDE5 enzyme.
Zdravilna učinkovina v zdravilu Adcirca, tadalafil, spada v skupino zdravil, imenovanih zaviralci fosfodiesteraze tipa 5 (PDE5), kar pomeni, da zavira encim PDE5.
The active substance in Adempas, riociguat, stimulates an enzyme called ‘soluble guanylate cyclase’ in the blood vessels of the lungs, which causes the blood vessels to relax and widen.
Zdravilna učinkovina v zdravilu Adempas, riociguat, spodbuja delovanje encima v krvnih žilah v pljučih, imenovanega „topna gvanilat-ciklaza“, s čimer povzroči, da se krvne žile sprostijo in razširijo.
The active substance in Advate, octocog alfa, is a substance that helps the blood to clot.
Zdravilna učinkovina zdravila Advate, oktokog alfa, je snov, ki pomaga pri strjevanju krvi.
The active substance in Afinitor, everolimus, is a cancer medicine, which acts by blocking a protein called ‘mammalian target of rapamycin’ (mTOR).
Zdravilna učinkovina zdravila Afinitor, everolimus, je zdravilo za zdravljenje raka, ki deluje z zaviranjem beljakovine, imenovane „tarča rapamicina pri sesalcih“ (mTOR).
The active substance in Alimta, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Zdravilna učinkovina zdravila Alimta, pemetreksed, je citotoksik (zdravilo, ki uničuje celice, ki se delijo, kot na primer rakave celice) iz skupine antimetabolitov.
The active substance in Aloxi, palonosetron, is a ‘5HT3 antagonist’.
Zdravilna učinkovina v zdravilu Aloxi, palonostreon, je „antagonist 5HT3“.
The active substance in Altargo, retapamulin, is an antibiotic belonging to the ‘pleuromutilin’ class.
Zdravilna učinkovina zdravila Altargo, retapamulin, je antibiotik iz skupine „pleuromutilinov“.
The active substance in Amyvid, florbetapir (18F), is a radiopharmaceutical that emits low amounts of radiation and works by targeting and attaching to β-amyloid plaques in the brain.
Zdravilna učinkovina v zdravilu Amyvid, florbetapir (18F), je radiofarmak, ki oddaja majhne količine sevanja in deluje tako, da se veže na β-amiloidne lehe v možganih.
The active substance in Apidra, insulin glulisine, is produced by a method known as ‘recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin glulisine.
Zdravilno učinkovino v zdravilu Apidra, insulin glulisin, proizvajajo z metodo, znano kot „tehnologija rekombinantne DNK“, Izdela ga bakterija, ki je prejela gen (DNK), s katerim lahko tvori insulin glulisin.
The active substance in Aprovel, irbesartan, is an ‘angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II.
Zdravilna učinkovina v zdravilu Aprovel, irbesartan, je antagonist receptorjev angiotenzina II, kar pomeni, da v telesu preprečuje delovanje hormona, imenovanega angiotenzin II.
The active substance in Armisarte, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites’.
Zdravilna učinkovina v zdravilu Armisarte, pemetreksed, je citotoksik (zdravilo, ki uničuje celice, ki se delijo, kot na primer rakave celice) iz skupine „antimetabolitov“.
The active substance in Arzerra, ofatumumab, is a monoclonal antibody.
Zdravilna učinkovina zdravila Arzerra, ofatumumab, je monoklonsko protitelo.
The active substance in Atriance, nelabarine, is a cytotoxic, a medicine that kills cells that are dividing, such as cancer cells.
Zdravilna učinkovina zdravila Atriance, nelarabin, je citotoksik, tj. zdravilo, ki uničuje celice v fazi delitve, na primer rakave celice.
The active substance in ATryn, antithrombin alfa, is a copy of the natural blood protein antithrombin, which is produced by ‘recombinant DNA technology’: it is extracted from the milk of goats that have had a gene (DNA) inserted, which makes them able to produce the human protein in their milk.
Zdravilna učinkovina zdravila ATryn, antitrombin alfa, je kopija naravne beljakovine v krvi, ki je proizvedena s tehnologijo rekombinantne DNK: pridobljena je iz mleka koz, ki so jim vstavili gen (DNK), s katerim lahko v svojem mleku tvorijo človeško beljakovino.
The active substance in Aubagio, teriflunomide, blocks an enzyme called ‘dihydro-orotate dehydrogenase’ which is necessary for cells to multiply.
Zdravilna učinkovina zdravila Aubagio, teriflunomid, zavira encim, imenovan „dihidroorotat-dehidrogenaza“, ki ga celice potrebujejo za razmnoževanje.